Sponsor:
Blue Lake Biotechnology Inc.
Code:
NCT05655182
Conditions
Respiratory Syncytial Virus Infections
Eligibility Criteria
Sex: All
Age: 6 - 5
Healthy Volunteers: Accepted
Interventions
PIV5-vectored RSV Vaccine (BLB-201) Low Dose
PIV5-vectored RSV Vaccine (BLB-201) High Dose
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-24. This information was provided to ClinicalTrials.gov by Blue Lake Biotechnology Inc. on 2024-08-27.